Stockreport

Skye Bioscience Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update [Yahoo! Finance]

Skye Bioscience, Inc.  (SKYE) 
PDF Faster-than-expected enrollment enables full top-line Phase 2a data in late Q3/early Q4 2025, ahead of schedule; interim analysis removed Phase 2a dosing extended to [Read more]